[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":8289000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":180000.0,"OperatingLeaseExpense_1_Q2_USD":260000.0,"OperatingLeaseExpense_2_Q2_USD":517000.0,"IncreaseDecreaseInDeferredRevenue_2_Q2_USD":-9756000.0,"DeferredRevenueCurrent_0_Q2_USD":32996000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-16249000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-32424000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":7693000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":13287000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":1335000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":8.44,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":72798000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-391000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":1955685.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":6.84,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":841581.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":17012000.0,"PaymentsOfDebtIssuanceCosts_2_Q2_USD":52000.0,"OtherAssetsNoncurrent_0_Q2_USD":90000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":31000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":15.39,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":6.07,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":11.54,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":4694324.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":407000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":1293000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":132382.0,"DeferredRentCreditNoncurrent_0_Q2_USD":146000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":709000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":72798000.0,"LettersOfCreditOutstandingAmount_0_Q2_USD":275000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":-51000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_2_Q2_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_2_Q2_USD":0.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"DeferredRevenueNoncurrent_0_Q2_USD":51652000.0,"DeferredRentCreditCurrent_0_Q2_USD":121000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleUnrealizedGainLoss_1_Q2_USD":-391000.0,"DebtSecuritiesAvailableForSaleUnrealizedGainLoss_2_Q2_USD":180000.0,"DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction_2_Q2_USD":315000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":31562000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":69417000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-308000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":407000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":1293000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":11.54,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":4694324.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":2946000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q2_USD":2489000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":2489000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":5033000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":75000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":133396000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":6.37,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-391000.0,"AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_0_Q2_USD":8289000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":9088000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":542000.0,"ShareBasedCompensation_2_Q2_USD":5033000.0,"Liabilities_0_Q2_USD":97082000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-916000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":64000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-1051000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-155000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-312000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-16013000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-32916000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":4195000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":8618000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.52,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.08,"LiabilitiesAndStockholdersEquity_0_Q2_USD":211999000.0,"CostsAndExpenses_1_Q2_USD":24113000.0,"CommonStockValue_0_Q2_USD":3000.0,"CommonStockSharesOutstanding_0_Q2_shares":30421775.0,"CommonStockSharesIssued_0_Q2_shares":30421775.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":133121000.0,"AssetsCurrent_0_Q2_USD":208610000.0,"Assets_0_Q2_USD":211999000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":4984771.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":4984771.0,"AdditionalPaidInCapital_0_Q2_USD":244807000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":224000.0,"AccountsReceivableNetCurrent_0_Q2_USD":3531000.0,"AccountsPayableCurrent_0_Q2_USD":3878000.0,"CostsAndExpenses_2_Q2_USD":47496000.0,"LiabilitiesCurrent_0_Q2_USD":45284000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":1338000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":65527000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":19918000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":38878000.0,"ProfessionalFees_0_Q2_USD":400000.0,"PreferredStockValue_0_Q2_USD":null,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"OperatingIncomeLoss_1_Q2_USD":-16420000.0,"OperatingIncomeLoss_2_Q2_USD":-34209000.0,"IncomeTaxesPaidNet_2_Q2_USD":480000.0,"DepreciationAndAmortization_2_Q2_USD":569000.0,"CommonStockSharesAuthorized_0_Q2_shares":400000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"AccruedLiabilitiesCurrent_0_Q2_USD":821000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":30360851.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":30274713.0,"StockholdersEquity_0_Q2_USD":114917000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-130117000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":3024000.0,"ProfitLoss_2_Q2_USD":-32604000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":681000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":2541000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":385000.0,"NetIncomeLoss_1_Q2_USD":-15858000.0,"NetIncomeLoss_2_Q2_USD":-32604000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-35303000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":116382.0,"RestrictedCash_0_Q2_USD":275000.0,"Ticker":"MORF","CIK":"1679363","name":"MORPHIC HOLDING, INC.","OfficialName":"Morphic Holding Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1330068663.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]